2013

Acne Vulgaris
Sponsor: Braintree Laboratories
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
12-45 Years
Phase: Phase 2
Start Date: February 2013
End Date: Date Here

Psoriasis
Sponsor: Maruho North America Inc.
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis 18 Years and Older
Phase: Phase 3
Start Date: June 2013
End Date: April 2015

Plaque Psoriasis
Sponsor: Therapeutics, Inc.
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
18 Years and Older
Phase: Phase 3
Start Date: June 2013
End Date: March 2014

Chronic Pruritus
Sponsor: Menlo Therapeutics Inc.
VPD-737 for Treatment of Chronic Pruritus
18-65 Years
Phase: Phase 2
Start Date: October 2013
End Date: April 2015

Atopic Dermatitis
Sponsor: Regeneron Pharmaceuticals | Sanofi
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis 18 Years and Older
Phase: Phase 3
Start Date: October 2013
End Date: December 2018

Acne Vulgaris
Sponsor: Cadila Healthcare Limited
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
12-40 Years
Phase: Phase 3
Start Date: November 2013
End Date: September 2016

Psoriasis
Sponsor: Promius Pharma, LLC
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
18 Years and Older
Phase: Phase 3
Start Date: November 2013
End Date: January 2015

Plaque Type Psoriasis
Sponsor: Sandoz | Hexal AG
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
18 Years and Older
Phase: Phase 3
Start Date: December 2013
End Date: February 2016